MENU
IMUX
AS OF
Nov 20, 04:59 PM (EDT)
Price
$0.68
Change
-$0.03 (-4.23%)
Capitalization
82.88M
91 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IMUX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunic (IMUX) Earnings Date & Reports

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis... Show more

A.I. Advisor
published Earnings

IMUX is expected to report earnings to fall 20.54% to -10 cents per share on February 19

Immunic IMUX Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Beat
by $0.02
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.01
The last earnings report on November 13 showed earnings per share of -12 cents, beating the estimate of -15 cents. With 1.87M shares outstanding, the current market capitalization sits at 82.88M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMUX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMUX showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for IMUX
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals and oral therapies for the treatment of chronic inflammatory and autoimmune diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1200 Avenue of the Americas
Phone
+1 332 255-9818
Employees
77
Web
https://www.imux.com